Multiple Myeloma an incurable disease, but I have spent the last 25 years in remission using a blend of conventional oncology and evidence-based nutrition, supplementation, and lifestyle therapies from peer-reviewed studies that your oncologist probably hasn't told you about.
Click the orange button to the right to learn more about what you can start doing today.
I am a long-term survivor of a blood cancer called multiple myeloma. I underwent Cytoxan aka cyclophosphamide chemotherapy in 9/95 and I underwent an autologous stem cell transplant several months later in 12/95. I developed chronic atrial fibrillation (Afib) in the fall of 2010. The studies linked and excerpted below are talking about me. I had an ASCT and I have a-fib.
I am also a MM cancer coach. I tell MMers who are considering an ASCT to understand the risks and benefits and to supplement with evidence-based, non-conventional therapies to reduce or eliminate the risk of future heart damage.
The question for those of us who have already had an ASCT and did not take preventative therapies is what, if anything, can we do about our heart damage?
Years of research have taught me that there are a host of heart-healthy supplements such as:
I supplement with all of the supplements listed above in addition to exercising moderately, eating nutritiously and getting plenty of sleep. I intend to live with my chronic a-fib for decades to come.
Have you been diagnosed with MM? Are you considering an autologous stem cell transplant? Please scroll down the page, post a question or comment and I will reply to you ASAP.
“Results from a recent retrospective study indicate that multiple myeloma patients who receive stem cell transplants may be at greater risk than the general population of developing atrial fibrillation, the most common type of irregular heartbeat…
The researchers suggest that selecting appropriate patients for stem cell transplantation, correcting risk factors, and using preventative treatment may prevent the occurrence of irregular heart beat in myeloma patients undergoing stem cell transplantation.”